Clinical Trial Update: A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 study of REGN7041 for active noninfectious uveitis affecting the posterior segment in adults, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Noninfectious Uveitis Affecting the Posterior Segment

Drugs mentioned

• REGN7041

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Active Noninfectious Uveitis Affecting the Posterior Segment | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING